InSphero scientists work closely with representatives from pharmaceutical and life science industries, academia, and regulatory agencies to help establish standards and protocols for using advanced 3D models in drug discovery and development. Our research team has validated and optimized 3D-cell-based assays and endpoints for several applications within the drug discovery and development cycle, spanning applications from the early phases to post-market in vitro studies. When you invest in 3D InSight™ discovery and safety platforms, you gain access to our proven 3D InSight™ microtissues, specially formulated media and rigorously tested inducers, as well as 3D-optimized technical protocols and expert support services these certified applications.
Research Areas
Metabolic Disease Discovery
β-cell Function & Insulin Secretagogues
α-cell Function & Glucagon Suppressors
Islet Viability & Apoptosis
β-cell Proliferation
Diabetes Type 1 & Type 2 Models
Dynamic Insulin Secretion
Drug-induced Pancreatic Endocrine Injury